Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
1.610
-0.020 (-1.23%)
At close: Dec 5, 2025, 4:00 PM EST
1.640
+0.030 (1.86%)
After-hours: Dec 5, 2025, 7:54 PM EST
Soligenix Market Cap
Soligenix has a market cap or net worth of $16.24 million as of December 5, 2025. Its market cap has increased by 82.46% in one year.
Market Cap
16.24M
Enterprise Value
6.10M
1-Year Change
82.46%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since December 1, 1998, Soligenix's market cap has decreased from $24.80M to $16.24M, a decrease of -34.52%. That is a compound annual growth rate of -1.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 16.20M | 138.24% |
| Dec 31, 2024 | 6.80M | -13.92% |
| Dec 29, 2023 | 7.90M | -59.49% |
| Dec 30, 2022 | 19.50M | -31.10% |
| Dec 31, 2021 | 28.30M | -25.92% |
| Dec 31, 2020 | 38.20M | 27.76% |
| Dec 31, 2019 | 29.90M | 96.71% |
| Dec 31, 2018 | 15.20M | -21.65% |
| Dec 29, 2017 | 19.40M | 128.24% |
| Dec 30, 2016 | 8.50M | -72.40% |
| Dec 31, 2015 | 30.80M | 42.59% |
| Dec 31, 2014 | 21.60M | -37.39% |
| Dec 31, 2013 | 34.50M | 414.93% |
| Dec 31, 2012 | 6.70M | 1.52% |
| Dec 30, 2011 | 6.60M | -83.90% |
| Dec 31, 2010 | 41.00M | -11.64% |
| Dec 31, 2009 | 46.40M | 660.66% |
| Dec 31, 2008 | 6.10M | -62.11% |
| Dec 31, 2007 | 16.10M | -2.42% |
| Dec 29, 2006 | 16.50M | 20.44% |
| Dec 30, 2005 | 13.70M | -49.07% |
| Dec 31, 2004 | 26.90M | -0.37% |
| Dec 31, 2003 | 27.00M | 167.33% |
| Dec 31, 2002 | 10.10M | -22.90% |
| Dec 31, 2001 | 13.10M | 3.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.37B |
| Johnson & Johnson | 487.04B |
| AbbVie | 403.71B |
| UnitedHealth Group | 300.16B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 251.43B |
| Abbott Laboratories | 216.65B |